Chunfeng WU, Lixian LIU, Jinlong HUO, Dalin LI, Yueyun YUAN, Feng YUAN, Yongwang MIAO

Molecular characterization of the encoding regions and tissue expression analyses for 3 novel buffalo AKT genes, AKT1, AKT2, and AKT3

The objective of this study was to obtain the complete coding sequences (CDSs) of 3 buffalo genes (AKT1, AKT2, and AKT3) using reverse-transcriptase polymerase chain reaction and to depict their molecular characterizations and tissue expression patterns in buffalo. The buffalo AKT1, AKT2, and AKT3 CDSs were 1443 bp, 1446 bp, and 1440 bp in length and encoded 480, 481, and 479 amino acids, respectively. Nine, 13, and 3 nucleotide differences were found in the CDSs between buffalo and other bovine species. Phylogenetic analyses showed that buffalo AKT1 and AKT2 have close genetic relationships with other species in the family Bovidae, while AKT3 is highly conserved in mammals. Buffalo AKT1, AKT2, and AKT3 all have a pleckstrin homology domain, a Ser/Thr-specific kinase domain, and a C-terminal hydrophobic regulatory domain. The tissue expression profiles were tested by real-time quantitative PCR and revealed that the buffalo AKTs were expressed in 10 tissues. Among these tissues, mammary glands showed high expression levels, which indicated that AKT genes might be important in the regulation of mammary gland functions in buffalo.

Anahtar Kelimeler:

Key words: Buffalo, AKT genes, polymorphism, characterization, tissue expression profile

Molecular characterization of the encoding regions and tissue expression analyses for 3 novel buffalo AKT genes, AKT1, AKT2, and AKT3

Keywords:

Key words: Buffalo, AKT genes, polymorphism, characterization, tissue expression profile,

PDF

___

Bellacosa A, Staal SP, Testa JR, Tsichlis PN (1991). A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 254: 274–277.
Bengoechea-Alonso MT, Ericsson J (2007). SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol 19: 215–222.
Bionaz M, Loor JJ (2011). Gene networks driving bovine mammary protein synthesis during the lactation cycle. Bioinform Biol Insights 5: 83–98.
Burgering BM, Coffer PJ (1995). Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599–602.
Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K et al. (2001). Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15: 2203–2208.
Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB 3rd, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ (2001). Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBbeta). Sci Signal 292: 1728.
Chodosh LA, Gardner HP, Rajan JV, Stairs DB, Marquis ST, Leder PA (2000). Protein kinase expression during murine mammary development. Dev Biol 219: 259–276.
Du X, Kristiana I, Wong J, Brown AJ (2006). Involvement of Akt in ER-to-Golgi transport of SCAP/SREBP: a link between a key cell proliferative pathway and membrane synthesis. Mol Biol Cell 17: 2735–2745.
Dummler B, Tschopp O, Hynx D, Yang ZZ, Dirnhofer S, Hemmings BA (2006). Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies. Mol Cell Biol 26: 8042–8051.
Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, de Jong R, Oltersdorf T et al. (2005). Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25: 1869–1878.
Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN (1995). The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727–736.
Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR et al. (2003). Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ. J Clin Invest 112: 197–208.
Geourjon C, Deleage G (1995). SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Comput Appl Biosci 11: 681–684.
Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, Hay N (2001). Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406–1418.
Hahn-Windgassen A, Nogueira V, Chen CC, Skeen JE, Sonenberg N, Hay N (2005). Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 280: 32081–32089.
Hers I, Vincent EE, Tavare JM (2011). Akt signalling in health and disease. Cell Signal 23: 1515–1527.
Kumar CC, Madison V (2005). AKT crystal structure and AKT- specific inhibitors. Oncogene 24: 7493–7501.
Kumar S, Nei M, Dudley J, Tamura K (2008). MEGA: a biologist- centric software for evolutionary analysis of DNA and protein sequences. Brief Bioinform 9: 299–306.
Lasserre R, Guo XJ, Conchonaud F, Hamon Y, Hawchar O, Bernard AM, Soudja SM, Lenne PF, Rigneault H, Olive D et al. (2008). Raft nanodomains contribute to Akt/PKB plasma membrane recruitment and activation. Nat Chem Biol 4: 538–547.
Liu X, Shi Y, Birnbaum MJ, Ye K, De Jong R, Oltersdorf T, Giranda VL, Luo Y (2006). Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions. J Bio Chem 281: 31380–31388.
Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2–ΔΔCT method. Methods 25: 402–408.
Petersen TN, Brunak S, von Heijne G, Nielsen H (2011). SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 8: 785–786.
Porstmann T, Griffiths B, Chung YL, Delpuech O, Griffiths JR, Downward J, Schulze A (2005). PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene 24: 6465–6481.
Radisky DC, Hartmann LC (2009). Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 14: 181–191.
Rudolph MC, Neville MC, Anderson SM (2007). Lipid synthesis in lactation: diet and the fatty acid switch. J Mammary Gland Biol Neoplasia 12: 269–281.
Schwertfeger KL, Richert MM, Anderson SM (2001). Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol 15: 867–881.
Sonnhammer EL, von Heijne G, Krogh A (1998). A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol 6: 175–182.
Tschopp O, Yang ZZ, Brodbeck D, Dummler BA, Hemmings- Mieszczak M, Watanabe T, Michaelis T, Frahm J, Hemmings BA (2005). Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis. Development 132: 2943–2954.
Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, Hochstrasser DF (1999). Protein identification and analysis tools in the ExPASy server. Methods Mol Biol 112: 531–552.
Yang ZZ, Tschopp O, Hemmings-Mieszczak M, Feng J, Brodbeck D, Perentes E, Hemmings BA (2003). Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem 278: 32124–32131.
Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, Gorgun C, Kwiatkowski DJ, Hotamisligil GS, Lee CH et al. (2011). Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 14: 21–32.